Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α

MLA

Elizabeth A. Spencer, et al. “Corrigendum: Poor Prognostic Factors of Pharmacokinetic Origin Predict Outcomes in Inflammatory Bowel Disease Patients Treated with Anti-Tumor Necrosis Factor-α.” Frontiers in Immunology, vol. 15, Feb. 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1383704.

APA

Elizabeth A. Spencer, Marla C. Dubinsky, Michael A. Kamm, Maria Chaparro, Paolo Gionchetti, Fernando Rizzello, Javier P. Gisbert, Emily K. Wright, Julien D. Schulberg, Amy L. Hamilton, Dermot P. B. McGovern, & Thierry Dervieux. (2024). Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1383704

Chicago

Elizabeth A. Spencer, Marla C. Dubinsky, Michael A. Kamm, Maria Chaparro, Paolo Gionchetti, Fernando Rizzello, Javier P. Gisbert, et al. 2024. “Corrigendum: Poor Prognostic Factors of Pharmacokinetic Origin Predict Outcomes in Inflammatory Bowel Disease Patients Treated with Anti-Tumor Necrosis Factor-α.” Frontiers in Immunology 15 (February). doi:10.3389/fimmu.2024.1383704.